当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析

微芯生物

(688321)

  

流通市值:141.22亿  总市值:141.22亿
流通股本:4.08亿   总股本:4.08亿

微芯生物(688321)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.30亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益161475.38万元,未分配利润3260.35万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产343480.32万元,负债182004.94万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入406,598,517.7162,263,736.11657,949,379.86481,115,043.66
营业总成本376,480,827.83181,685,156.93735,520,875.8519,910,892.74
其他经营收益
营业利润28,120,919.48-18,597,145.82-178,502,793.33-44,897,880.57
利润总额28,065,637.36-18,596,691.33-96,711,888.26-44,890,516.29
净利润29,592,228.83-19,154,672.71-114,570,600.33-51,084,939.83
每股收益
其他综合收益-209,350.4-81,678.3754,998.1-503,438.33
综合收益总额29,382,878.43-19,236,351.01-113,815,602.23-51,588,378.16
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,246,399,390.821,134,827,622.721,083,471,551.641,098,609,675.59
非流动资产:
非流动资产合计2,188,403,802.32,176,875,505.652,167,427,506.542,239,531,491.83
资产总计3,434,803,193.123,311,703,128.373,250,899,058.183,338,141,167.42
流动负债:
流动负债合计650,505,729.15481,443,280.53451,311,494.66380,356,760.29
非流动负债:
非流动负债合计1,169,543,706.341,268,397,450.081,218,488,814.751,314,473,443.75
负债合计1,820,049,435.491,749,840,730.611,669,800,309.411,694,830,204.04
所有者权益(或股东权益):
归属于母公司股东权益合计1,614,753,757.631,561,862,397.761,581,098,748.771,643,310,963.38
股东权益合计1,614,753,757.631,561,862,397.761,581,098,748.771,643,310,963.38
负债和股东权益合计3,434,803,193.123,311,703,128.373,250,899,058.183,338,141,167.42
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计433,184,403.84214,206,916.99747,991,861.67596,362,199.77
经营活动现金流出小计371,125,906.32194,227,068.7671,863,584.36521,797,905.23
经营活动产生的现金流量净额62,058,497.5219,979,848.2976,128,277.3174,564,294.54
投资活动产生的现金流量:
投资活动现金流入小计696,041,367.29290,169,761.161,376,083,402.571,106,464,509.65
投资活动现金流出小计745,964,987.8347,281,222.091,672,117,566.251,386,493,392.38
投资活动产生的现金流量净额-49,923,620.51-57,111,460.93-296,034,163.68-280,028,882.73
筹资活动产生的现金流量:
筹资活动现金流入小计197,000,000125,000,000408,185,670295,000,000
筹资活动现金流出小计102,310,830.1766,437,641.14232,822,847.19162,858,074.51
筹资活动产生的现金流量净额94,689,169.8358,562,358.86175,362,822.81132,141,925.49
汇率变动对现金及现金等价物的影响-77,413.06-143,302.02394,133.86-293,029.62
现金及现金等价物净增加额106,746,633.7821,287,444.2-44,148,929.7-73,615,692.32
期末现金及现金等价物余额329,287,042.64243,827,853.06222,540,408.86193,073,646.24
补充资料:
现金及现金等价物的净增加额106,746,633.78--44,148,929.7-
最新报告期:2025-08-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋张懿,谭紫媚0.200.260.362025-08-30
财通证券华挺0.140.420.822025-08-26
TOP↑